| 查看: 147 | 回复: 0 | |||
| 当前主题已经存档。 | |||
lxl8506铜虫 (正式写手)
|
[交流]
800金英译中文章"多酸被证为纳摩尔非竞争性的蛋白激酶CK2抑制剂"23日止
|
||
|
题目:Identification of Polyoxometalates as Nanomolar Noncompetitive Inhibitors of Protein Kinase CK2 Summary Protein kinase CK2 is a multifunctional kinase of medical importance that is dysregulated in many cancers. In this study, polyoxometalates were identified as original CK2 inhibitors. [P2Mo18O62]6− has the most potent activity. It inhibits the kinase in the nanomolar range by targeting key structural elements located outside the ATP- and peptide substrate-binding sites. Several polyoxometalate derivatives exhibit strong inhibitory efficiency, with IC50 values ≤ 10 nM. Furthermore, these inorganic compounds show a striking specificity for CK2 when tested in a panel of 29 kinases. Therefore, polyoxometalates are effective CK2 inhibitors in terms of both efficiency and selectivity and represent nonclassical kinase inhibitors that interact with CK2 in a unique way. This binding mode may provide an exploitable mechanism for developing potent drugs with desirable properties, such as enhanced selectivity relative to ATP-mimetic inhibitors. PDF图文表共730KB 但总是传不上 联系lxl8506@sina.com 谢谢了 |
回复此楼» 猜你喜欢
酰胺脱乙酰基
已经有9人回复
-
有时候真觉得大城市人没有县城人甚至个体户幸福
已经有3人回复
-
CSC & MSCA 博洛尼亚大学能源材料课题组博士/博士后招生｜MSCA经费充足、排名优
已经有5人回复
-
有70后还继续奋斗在职场上的吗？
已经有6人回复
-
博士延得我，科研能力直往上蹿
已经有7人回复
-
退学或坚持读
已经有27人回复
-
面上基金申报没有其他的参与者成吗
已经有5人回复
-
遇见不省心的家人很难过
已经有22人回复